NOS substrate during cardioplegic arrest and cold storage decreases stunning after heart transplantation in a rat model

Journal of Heart and Lung Transplantation

Volumn 22, Issue 2, 2003, Pages 184-191

  Caus, Thierry ^a,b   Desrois, Martine ^a   Izquierdo, Marguerite ^a   Lan, Carole ^a   LeFur, Yann ^a   Confort Gouny, Sylviane ^a   Métras, Dominique ^b   Clarke, Kieran ^c   Cozzone, Patrick J ^a   Bernard, Monique ^a  

^a University of Aix Marseille   (France)

^b TIMONE HOSPITAL   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CARDIOPLEGIC AGENT; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CRYOPRESERVATION; ENERGY METABOLISM; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HIGH ENERGY PHOSPHATE; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; STUNNED HEART MUSCLE; SYSTOLE; WESTERN BLOTTING;

ALLOPURINOL; ANIMALS; ARGININE; BLOTTING, WESTERN; CARDIOPLEGIC SOLUTIONS; COLD; GLUTATHIONE; HEART ARREST, INDUCED; HEART TRANSPLANTATION; MYOCARDIAL REPERFUSION; MYOCARDIAL STUNNING; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN PRESERVATION; RAFFINOSE; RATS; RATS, INBRED LEW;

EID: 0037314333     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00495-3     Document Type: Article

References (31)

1. Caus T., Izquierdo M., Lan C., et al. Simultaneous study of metabolism and function following cardioplegic arrest a novel method of evaluation of the transplanted heart in the rat. J Heart Lung Transplant. 20:2001;575-582.
2. Kevelaitis E., Mouas C., Menasche P. Poststorage diastolic abnormalities of heart transplants is vascular dysfunction or myocardial contracture the culprit? J Heart Lung Transplant. 15:1996;461-469.
3. Amrani M., Gray C.C., Smolenski R.T., Goodwin A.T., London A., Yacoub M.H. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia. Circulation. 96:1997;ii274-279.
4. Desrois M., Sciaky M., Lan C., Cozzone P.J., Bernard M. L-arginine during long-term ischemia effects on cardiac function, energetic metabolism and endothelial damage. J Heart Lung Transplant. 19:2000;367-376.
5. Szabo G., Bahrle S., Batkai S., et al. L-arginine effect on reperfusion injury after heart transplantation. World J Surg. 22:1998;791-797.
6. Matheis G., Sherman M., Buckberg G., Haybron D., Young H., Ignarro L. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol. 262:1992;H616-620.
7. Takeuchi K., McGowan F., Danh H., Glynn P., Simplaceanu E., Del Nido P. Direct detrimental effects of L-arginine upon ischemia-reperfusion injury to myocardium. J Mol Cell Cardiol. 27:1995;1405-1414.
8. Bernard M., Caus T., Sciaky M., Lan C., Cozzone P.J. Optimized cardiac graft preservation a comparative experimental study using P-31 magnetic resonance spectroscopy and biochemical analyses. J Heart Lung Transplant. 18:1999;572-581.
9. Gödecke A., Decking U.K.M., Ding Z., et al. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res. 82:1998;186-194.
10. Caus T., Bernard M., Sciaky M., Monties J.R., Cozzone P.J. Heterotopic rat heart transplant as an in vivo model for reperfusion in long term heart preservation with a modified UW solution. Transplant Proc. 28:1996;367.
11. Mizuno T., Watanabe M., Sakamoto T., Sunamori M. L-arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate. J Thorac Cardiovasc Surg. 115:1998;931-936.
12. Pinsky D.J., Oz M.C., Koga S., et al. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest. 93:1994;2291-2297.
13. Stowe D.F., Boban M., Roerig D.L., Chang D., Palmisano B.W., Bosnjak Z.J. Effects of L-arginine and N omega-nitro-L-arginine methyl ester on cardiac perfusion and function after 1-day cold preservation of isolated hearts. Circulation. 95:1997;1623-1634.
14. Szabo G., Batkai S., Bahrle S., et al. Effects of nitric oxide synthesis on reperfusion injury and catecholamine responsiveness in a heterotopic rat heart-transplantation model. J Cardiovasc Pharmacol. 31:1998;221-230.
15. Wiedermann C.J., Sitte B., Zilian U., et al. Inhibition of superoxide anion release from circulating neutrophils by L-arginine in man. Clin Investig. 71:1993;985-989.
16. Amrani M., Chester A.H., Jakyakumar C.J., Scyns C.J., Yacoub M.H. L-Arginine reverses low coronary reflow and enhances postischemic recovery of cardiac mechanical function. Cardiovasc Res. 30:1995;200-204.
17. Kelm M., Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res. 66:1990;1561-1575.
18. Pohl U., Lamontagne D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res Cardiol. 86:1991;97-105.
19. Lefer D.J., Scalia R., Campbell B., et al. Peroxynitrite inhibits leucocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest. 99:1997;684-691.
20. Pabla R., Buda A.J., Flynn D.M., et al. Nitric oxide attenuates neutrophil-mediated contractile dysfunction after ischemia and reperfusion. Circ Res. 78:1996;65-72.
21. Ma X.L., Weyrich A.S., Lefer D.J., Lefer A.M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 72:1993;403-412.
22. Kurose I., Wolf R., Grisham M., Granger D. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res. 74:1994;376-382.
23. Loscalzo J. What we know and don't know about L-arginine and NO. Circulation. 101:2000;2126-2129.
24. 2+-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart. J Cardiovasc Pharmacol. 29:1997;291-296.
25. Nagase S., Takemura K., Ueda A., et al. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem Biophys Res Commun. 233:1997;150-153.
26. Redondo J., Manso A.M., Pacheco M.E., Hernandez L., Salaices M., Marin J. Hypothermic storage of coronary endothelial cells reduces nitric oxide synthase activity and expression. Cryobiology. 41:2000;292-300.
27. Baldwin W.R., Samaniego-Picota M., Kasper E., et al. Complement deposition in early cardiac biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation. 68:1999;894-900.
28. Lee J., Drinkwater D., Laks H., et al. Preservation of endothelium-dependent vasodilatation with low-potassium University of Wisconsin solution. J Thorac Cardiovasc Surg. 112:1996;103-110.
29. Kirklin J., McGiffin D. Control of the inflammatory response in extended myocardial preservation of the donor heart. Ann Thorac Surg. 68:1999;1978-1982.
30. John R., Rajasinghe H., Itescu S., et al. Factors affecting long term survival (>10 years) after cardiac transplantation in the cyclosporine era. J Am Coll Cardiol. 37:2001;189-194.
31. Engelman D., Watanabe M., Maulik N., et al. Critical timing of nitric supplementation in cardioplegic arrest and reperfusion. Circulation. 94:1996;I407-411.